NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 9 min 2 sec ago
Notice of Correction to Award Budget in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"
Notice NOT-CA-23-077 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to modify the label to R and R Budget" for RFA-RM-23-005 "NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)"
Notice NOT-RM-23-020 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Advancing Research to Address the Heterogeneity of Obesity Risk, Related Health Outcomes, and Response to Treatment
Notice NOT-HL-23-090 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend the Due Date and Expiration Date of NOT-TR-23-019: Notice of Special Interest (NOSI): Availability of Administrative Supplements for Submission to the ASPIRE (A Specialized Platform for Research Exploration) Collaborative Research Program
Notice NOT-TR-23-025 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification to PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
Notice NOT-DA-23-029 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Pre-Application Webinar for Funding Opportunity RFA-AG-23-016, "Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)"
Notice NOT-AG-23-038 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed)
Funding Opportunity RFA-OD-23-018 from the NIH Guide for Grants and Contracts. The NIH Office of Disease Prevention (ODP) and participating Institutes, Centers, and Offices are soliciting T32 applications to train predoctoral scholars from diverse backgrounds, including those underrepresented in prevention relevant fields, in three integrated areas: 1) health disparities/health equity research, 2) development and implementation of multi-level preventive interventions, and 3) methods for the design and analysis of studies to evaluate multi-level preventive interventions (see Notice of NIH's Interest in Diversity).
Categories: Job Watch, Literature Watch
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-23-011 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to collect human biological samples or environmental exposure data. The primary motivation of the FOA is to understand the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad. A distinguishing feature of an appropriate study is the need for rapid review and funding, substantially shorter than the typical NIH grant review/award cycle, for the research question to be addressed and swiftly implemented.
Categories: Job Watch, Literature Watch
Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required)
Funding Opportunity RFA-AG-24-048 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support research that can lead to the development of evidence-based primary care screening tools and behavioral interventions to prevent abuse in at-risk older and vulnerable adults with mild cognitive impairment (MCI) and Alzheimers disease (AD) and Alzheimer's disease-related dementias (ADRD) and their families.
Categories: Job Watch, Literature Watch
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-TR-23-016 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.
Categories: Job Watch, Literature Watch
Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)
Funding Opportunity RFA-AG-24-039 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to develop and validate the standardized protocols for measuring nicotinamide adenine dinucleotide (NAD+) and related metabolites levels in humans, including sample collection and storage, assays calibration, and standardization of measurements across different types of samples such as plasma, tissue, or serum extracts, and validation of these protocols. Limited preclinical animal studies could be proposed by the applicants, if such studies are integral part of the applications and if they are needed to test the select elements of the standardized protocols in animal models before such protocols could be tested in humans. The proposed studies will be funded by individual awards, but the awardees will be required to interact as a network to exchange information, discuss their progress, pitfalls and issues arising during studies implementation.
Categories: Job Watch, Literature Watch
Single Source : NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
Funding Opportunity RFA-EB-23-003 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support the NeuroImaging Tools and Resources Collaboratory and to enable collaborative research in neuroimaging informatics. The competition is limited to the U24 awardees and subawardees of RFA-EB-16-002.
Categories: Job Watch, Literature Watch
Notice of Correction to the Application Types Allowed Information for RFA-AG-23-016, Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
Notice NOT-AG-23-041 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish the Reissuance of RFA-AG-23-003, "Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)"
Notice NOT-AG-23-036 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Information (RFI): Soliciting data on the impact of telehealth initiation of controlled substances permitted under the COVID-19 Public Health Emergency (PHE)
Notice NOT-DA-23-028 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIDA Participation in RFA-NS-22-022, RFA-NS-22-023, RFA-NS-22-024, RFA-NS-22-025, "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research"
Notice NOT-DA-23-026 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates for RFA-NS-24-009: Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
Notice NOT-NS-24-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Notice NOT-OD-23-147 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
Notice NOT-OD-23-146 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Extramural Loan Repayment Program for Research in Emerging Areas Critical to Human Health (LRP-REACH)
Notice NOT-OD-23-145 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch